Question 1

What is the catalog number for 2H-Pyrido[4,3-b][1,4]oxazin-3 (4H) -one?

Accepted Answer

The catalog number for 2H-Pyrido[4,3-b][1,4]oxazin-3 (4H) -one is OR77156.

Question 2

What sizes are available for 2H-Pyrido[4,3-b][1,4]oxazin-3 (4H) -one?

Accepted Answer

2H-Pyrido[4,3-b][1,4]oxazin-3 (4H) -one is available in the following size(s): 1 Each.

Question 3

Is 2H-Pyrido[4,3-b][1,4]oxazin-3 (4H) -one in stock?

Accepted Answer

2H-Pyrido[4,3-b][1,4]oxazin-3 (4H) -one is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.

Question 5

Can I return this product if I ordered the wrong one?

Accepted Answer

As a consumer, you have a 14-day right of withdrawal from receipt under EU consumer protection law, submitted via our withdrawal/cancellation request form. Note this applies to unused, undamaged products, and doesn’t override the expiry/storage conditions on performance-based claims.

Question 6

Is this product tested for endotoxin levels?

Accepted Answer

Endotoxin testing status is noted on the datasheet where applicable, particularly for recombinant proteins intended for cell-based or functional assays. If this isn’t listed and you need confirmation, contact support with the catalogue number.

2H-Pyrido[4,3-b][1,4]oxazin-3 (4H) -one

Product Specifications

CAS Number

MDL Number

Purity

Smiles

Frequently Asked Questions

Explore Other Products

GP2 (Glycoprotein 2) / ZAP75 (GP2/2569R), 0.2mg/mL

CD68 (Macrophage Marker) (LAMP4/1830), CF647 conjugate, 0.1mg/mL

CD30 / TNFRSF8 (Hodgkin & Reed-Sternberg Cell Marker) (rKi-1/779), CF640R conjugate, 0.1mg/mL

SOX2 (Embryonic Stem Cell Marker) (SOX2/3169R), CF405S conjugate, 0.1mg/mL

CD70 (TNFS7/1026), CF568 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, 0.1mg/mL